Abbott India surges on reporting 0.64% rise in Q2 net profit

14 Aug 2013 Evaluate

Abbott India is currently trading at Rs. 1370.00, up by 8.95 points or 0.66% from its previous closing of Rs. 1361.05 on the BSE.

The scrip opened at Rs. 1361.00 and has touched a high and low of Rs. 1375.00 and Rs. 1361.00 respectively. So far 366 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1650.00 on 06-Sep-2012 and a 52 week low of Rs. 1306.00 on 25-Mar-2013.

Last one week high and low of the scrip stood at Rs. 1381.95 and Rs. 1321.00 respectively. The current market cap of the company is Rs. 2,911 crore.

The promoters holding in the company stood at 74.99% while Institutions and Non-Institutions held 7.36% and 17.65% respectively.

The company has reported 0.64% rise in its net profit at Rs 29.71 crore for the quarter as compared to Rs 29.52 crore for the same quarter in the previous year. Total income from operations of the company has increased by 6.93% at Rs 440.21 crore for quarter under review as compared to Rs 411.67 crore for the quarter ended June 30, 2012.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services. In 1888 a young Chicago physician, Dr Wallace Calvin Abbott founded Abbott Laboratories.

Abbott India Share Price

28659.60 -209.75 (-0.73%)
08-Dec-2025 09:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1796.25
Dr. Reddys Lab 1274.40
Cipla 1512.50
Zydus Lifesciences 934.40
Lupin 2094.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×